SCHEDULE 13G: WeRide Inc. Founder Yan Li Discloses Significant Beneficial Ownership and Voting Power

Dr. Yan Li, through affiliated entities, has disclosed beneficial ownership of 6.1% of WeRide Inc.'s Class A ordinary shares, representing 26.5% of the total outstanding voting power, as of December 31, 2024.

Summary

• Dr. Yan Li, a citizen of China, beneficially owns 48,060,900 shares of WeRide Inc., which includes Class A and Class B ordinary shares held by Yanli Holdings Limited and Humber Partners Limited, as well as Class B options exercisable within 60 days.
• This ownership translates to 6.1% of the Class A ordinary shares and a significant 26.5% of the total outstanding voting power of WeRide Inc.
• Yanli Holdings Limited, a British Virgin Islands company controlled by Dr. Yan Li, beneficially owns 16,000,010 shares, representing 2.1% of Class A ordinary shares and 0.5% of total voting power.
• Humber Partners Limited, also a British Virgin Islands company controlled by Dr. Yan Li, beneficially owns 24,694,489 shares, representing 3.1% of Class A ordinary shares and 18.7% of total voting power.
• The calculation of ownership percentages is based on 771,399,682 issued and outstanding Class A ordinary shares as of December 31, 2024, including convertible Class B shares and exercisable options.
• WeRide Inc. has a dual-class share structure where Class A ordinary shares carry one vote per share, and Class B ordinary shares carry 40 votes per share, with Class B shares convertible into Class A shares on a one-to-one basis.
• Dr. Yan Li expressly disclaims the existence of a 'group' with Dr. Tony Xu Han or Alliance Ventures, B.V., despite a nominating and support agreement that allows Alliance Ventures, B.V. to appoint, remove, and replace two directors.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain subjective language or performance metrics that would indicate a positive or negative sentiment. It is neutral.

Risks

• The reporting person, Dr. Yan Li, expressly disclaims the existence of a 'group' with Dr. Tony Xu Han or Alliance Ventures, B.V., which could be a point of scrutiny or potential future dispute regarding control or influence.

Industry Context

This Schedule 13G filing is a standard regulatory disclosure of significant ownership stakes, common across all industries. It provides transparency regarding the control structure of WeRide Inc., a company likely involved in the autonomous driving or related technology sector, given its name and the nature of its shares.

Corporate Governance

Related Party Transactions

• Dr. Yan Li holds 51% equity interests in Yanli Holdings Limited through Humber Partners Limited, which is 100% owned by Dr. Yan Li. Dr. Li is also the sole director of Yanli Holdings Limited. This establishes a direct control relationship between Dr. Yan Li and the two corporate reporting entities, Yanli Holdings Limited and Humber Partners Limited, making their shareholdings related party interests.

Stakeholder Impact

• Shareholders: The disclosure clarifies the significant voting power held by Dr. Yan Li, particularly through the high-vote Class B ordinary shares, which could influence corporate control and strategic direction. This concentration of voting power may affect the influence of other Class A shareholders.
• Management: The nominating and support agreement involving Alliance Ventures, B.V. suggests a structured approach to board appointments, potentially influencing management's operational autonomy and strategic alignment.

Key Dates

Keywords

WeRide Inc., Yan Li, Schedule 13G, Beneficial Ownership, Voting Power, Class A Ordinary Shares, Class B Ordinary Shares, SEC Filing, Corporate Governance, Shareholder Disclosure